Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06952517
PHASE2
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
Sponsor: Narrows Institute for Biomedical Research
View on ClinicalTrials.gov
Summary
To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.
Official title: Efficacy and Safety of Topical Clascoterone Cream 1% in Patients With Facial Acneiform Rosacea
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-03-14
Completion Date
2025-09-30
Last Updated
2025-05-06
Healthy Volunteers
Yes
Interventions
DRUG
Clascoterone Cream 1%
Clascoterone 1% cream
Locations (1)
New York Harbor VA Brooklyn Campus
Brooklyn, New York, United States